|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharm Exec's 2019 Pipeline Reportalmost 8 years ago
High-Risk Marketing Violations Draw Scrutinyalmost 8 years ago
Biopharma Business Checkalmost 8 years ago
Patent Protection for Cannabis?almost 8 years ago
Steadying the Path of Good Sciencealmost 8 years ago
Southeast Biotech: Rising Tall in the Valleyalmost 8 years ago
Fighting for a Streamlined European HTA Schemealmost 8 years ago
Stunted Innovation in Drug Development?almost 8 years ago
Country Report: AlgeriaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5